181 related articles for article (PubMed ID: 7575451)
1. Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations.
Thomas TJ; Gunnia UB; Seibold JR; Thomas T
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):175-82. PubMed ID: 7575451
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase.
Gunnia UB; Amenta PS; Seibold JR; Thomas TJ
Kidney Int; 1991 May; 39(5):882-90. PubMed ID: 2067204
[TBL] [Abstract][Full Text] [Related]
3. Polyamine-fas interactions: inhibition of polyamine biosynthesis in MRL-lpr/lpr mice is associated with the up-regulation of fas mRNA in thymocytes.
Hsu HC; Thomas T; Sigal LH; Thomas TJ
Autoimmunity; 1999; 29(4):299-309. PubMed ID: 10433086
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ornithine decarboxylase in the kidney of autoimmune mice with the lpr gene.
Hsu HC; Seibold JR; Thomas TJ
Autoimmunity; 1994; 19(4):253-64. PubMed ID: 7578852
[TBL] [Abstract][Full Text] [Related]
5. Restoration of the DNA binding activity of estrogen receptor in MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor.
Thomas T; Gunnia UB; Seibold JR; Thomas TJ
Arthritis Rheum; 1991 Jan; 34(1):55-62. PubMed ID: 1984779
[TBL] [Abstract][Full Text] [Related]
6. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
Hsu HC; Thomas T; Seibold JR; Thomas TJ
Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
[TBL] [Abstract][Full Text] [Related]
7. Reversal of the abnormal development of T cell subpopulations in the thymus of autoimmune MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor.
Thomas TJ; Gunnia UB; Thomas T
Autoimmunity; 1992; 13(4):275-83. PubMed ID: 1472637
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice.
Thomas TJ; Messner RP
Clin Exp Immunol; 1989 Nov; 78(2):239-44. PubMed ID: 12412756
[TBL] [Abstract][Full Text] [Related]
9. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
Budd RC; Winslow G; Inokuchi S; Imboden JB
J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
[TBL] [Abstract][Full Text] [Related]
10. Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity.
Sjöholm A; Arkhammar P; Welsh N; Bokvist K; Rorsman P; Hallberg A; Nilsson T; Welsh M; Berggren PO
J Clin Invest; 1993 Oct; 92(4):1910-7. PubMed ID: 8408643
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium signalling in murine splenocytes by polyamines: differential effects on CD4 and CD8 T-cells.
Thomas T; Gunnia UB; Yurkow EJ; Seibold JR; Thomas TJ
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):375-81. PubMed ID: 8097908
[TBL] [Abstract][Full Text] [Related]
12. Constitutive turnover of inositol-containing phospholipids in B220+ T cells from autoimmune-prone MRL-lpr/lpr mice.
Tomita-Yamaguchi M; Santoro TJ
J Immunol; 1990 May; 144(10):3946-52. PubMed ID: 1692067
[TBL] [Abstract][Full Text] [Related]
13. Abnormal signal transduction through CD4 leads to altered tyrosine phosphorylation in T cells derived from MRL-lpr/lpr mice.
Duan JM; Fagard R; Madaio MP
Autoimmunity; 1996; 23(4):231-43. PubMed ID: 8915030
[TBL] [Abstract][Full Text] [Related]
14. The effect of alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on mitogen-induced interleukin 2 production.
Bowlin TL; McKown BJ; Sunkara PS
Immunopharmacology; 1987 Apr; 13(2):143-7. PubMed ID: 3110101
[TBL] [Abstract][Full Text] [Related]
15. Defective signal transduction in CD4-CD8- T cells of lpr mice.
Stafford-Brady F; Sugiyama E; Robinson DR; Sy MS; Bonventre JV; Yeh ET
Cell Immunol; 1989 Oct; 123(2):396-404. PubMed ID: 2551509
[TBL] [Abstract][Full Text] [Related]
16. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
17. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Prendergast RA
Curr Eye Res; 1997 Sep; 16(9):909-16. PubMed ID: 9288452
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
20. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
Drappa J; Brot N; Elkon KB
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
